These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21368795)

  • 21. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.
    Paxton WA; Neumann AU; Kang S; Deutch L; Brown RC; Koup RA; Wolinsky SM
    J Infect Dis; 2001 Jun; 183(11):1678-81. PubMed ID: 11343219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV/AIDS. HIV: experiencing the pressures of modern life.
    Nolan D; James I; Mallal S
    Science; 2005 Mar; 307(5714):1422-4. PubMed ID: 15746416
    [No Abstract]   [Full Text] [Related]  

  • 23. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
    Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
    PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
    Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
    J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes.
    Patterson BK; Czerniewski M; Andersson J; Sullivan Y; Su F; Jiyamapa D; Burki Z; Landay A
    Clin Immunol; 1999 Jun; 91(3):254-62. PubMed ID: 10370370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine modulation of HIV-1 chemokine receptor expression.
    Landay AL; Patterson B; Andersson J
    Nat Med; 1999 Jun; 5(6):592-3. PubMed ID: 10371480
    [No Abstract]   [Full Text] [Related]  

  • 27. CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE).
    Moss RB; Giermakowska WK; Diveley JP; Savary JR; Wallace MR; Maigetter RZ; Jensen FC; Carlo DJ
    J Hum Virol; 2000; 3(1):44-9. PubMed ID: 10774806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.
    Levine BL; Bernstein WB; Aronson NE; Schlienger K; Cotte J; Perfetto S; Humphries MJ; Ratto-Kim S; Birx DL; Steffens C; Landay A; Carroll RG; June CH
    Nat Med; 2002 Jan; 8(1):47-53. PubMed ID: 11786906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease: Closing the door on HIV.
    Eisenstein M
    Nature; 2015 Dec; 528(7580):S8-9. PubMed ID: 26630600
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical Applications of Genome Editing to HIV Cure.
    Wang CX; Cannon PM
    AIDS Patient Care STDS; 2016 Dec; 30(12):539-544. PubMed ID: 27854119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural resistance to HIV?
    Hill CM; Littman DR
    Nature; 1996 Aug; 382(6593):668-9. PubMed ID: 8751431
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gene therapy in HIV infection: proof-of-concept in 12 patients].
    ; Epaulard O
    Med Mal Infect; 2014 May; 44(5):239-40. PubMed ID: 25035879
    [No Abstract]   [Full Text] [Related]  

  • 35. Engineering cellular resistance to HIV.
    Kay MA; Walker BD
    N Engl J Med; 2014 Mar; 370(10):968-9. PubMed ID: 24597871
    [No Abstract]   [Full Text] [Related]  

  • 36. CD4+ T cell surface CCR5 density and virus load in persons infected with human immunodeficiency virus type 1.
    Marmor M; Krowka J; Goldberg JD
    J Infect Dis; 2000 Oct; 182(4):1284-6. PubMed ID: 10979936
    [No Abstract]   [Full Text] [Related]  

  • 37. Functional phenotypes of CCR5 on CD4+ T cells of relevance to its genetic and epigenetic associations with HIV infection.
    Skundric DS; Tse HY; Montgomery PC
    Cell Mol Immunol; 2020 Jul; 17(7):680-681. PubMed ID: 31900454
    [No Abstract]   [Full Text] [Related]  

  • 38. Dichotomous effects of Plasmodium falciparum antigens on expression of human immunodeficiency virus (HIV) coreceptors and on infectability of CD4 cells by HIV.
    Moriuchi M; Moriuchi H; Mon HM; Kanbara H
    J Infect Dis; 2002 Oct; 186(8):1194-7. PubMed ID: 12355376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic HIV vaccines show promise.
    Abbott A
    Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679
    [No Abstract]   [Full Text] [Related]  

  • 40. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.